Drug Chatter -- Tracking biopharma stock chatter

Profile for OXiGENE, Inc. (OXGN)

« Back to company index

OXGN Chatter Timeline

Stock Ticker for OXGN

Most Active Tweeters for OXGN

UserTweets
@jeff90lx 1

Recent Tweets for OXGN

jeff90lx @jeff90lx
RT @Allstocknews: $OXGN Mateon Therapeutics Announces New Interim Preclinical Data on CA4P in Combination with Checkpoint Inhib From our St…
July 17th 2017, 11:07pm
Allstocknews @Allstocknews
$OXGN Mateon Therapeutics Announces New Interim Preclinical Data on CA4P in Combination with Checkpoint Inhib From our Stock News Alerts App
June 28th 2017, 7:06am
Allstocknews @Allstocknews
$OXGN New SEC Document(s) for Mateon Therapeutics From our Stock News Alerts App
June 13th 2017, 9:06am
Newswire_world @Newswire_world
Edgar 8K Mon, 12 Jun 2017 12:15:55 UTC MATEON THERAPEUTICS INC $OXGN https://t.co/9zfivYJ9gl Price=0.74 Vol:169586
June 12th 2017, 8:06am
danwardbio @danwardbio
RT @bio_clouseau: $MATN F/K/A $OXGN IST Ovarian cancer P1/2 trial suspended due to 2 AE's
June 12th 2017, 8:06am
bio_clouseau @bio_clouseau
$MATN F/K/A $OXGN IST Ovarian cancer P1/2 trial suspended due to 2 AE's
June 12th 2017, 7:06am
MyAlliesTrading @MyAlliesTrading
$OXGN Mateon Therapeutics Provides Update on its Clinical Trial Programs and Milestones https://t.co/k1ozwgTo27
June 12th 2017, 7:06am
Allstocknews @Allstocknews
$OXGN Mateon Therapeutics Provides Update on its Clinical Trial Programs and Milestones From our Stock News Alerts App
June 12th 2017, 7:06am
MyAlliesTrading @MyAlliesTrading
$OXGN Mateon Therapeutics Receives FDA Fast Track Designation for OXi4503 in Patients with Acute Myeloid Leuk... https://t.co/afcgCGMlhN
June 9th 2017, 9:06pm
box_of_news @box_of_news
$OXGN: New SEC Filing for OXGN: Form 8-K (No. 0001193125-17-200187): https://t.co/LhnHXAw0nR
June 9th 2017, 5:06pm
box_of_news @box_of_news
$OXGN: New SEC Filing for OXGN: Form 8-K (No. 0001193125-17-196628): https://t.co/o3GUl6Jgr7
June 7th 2017, 10:06am
QLFilings @QLFilings
$OXGN filed Form 8-K with the SEC. Most mentioned words: mateon, oxi, exchange, aml, treatment
June 7th 2017, 10:06am
BursatilBiotech @BursatilBiotech
RT @BioStocks: $MATN (fka $OXGN) Receives FDA Fast Track Designation for OXi4503 in Patients with AML
June 7th 2017, 8:06am
Allstocknews @Allstocknews
$OXGN Mateon Therapeutics Receives FDA Fast Track Designation for OXi4503 in Patients with Acute Myeloid Leu From our Stock News Alerts App
June 7th 2017, 7:06am
BioStocks @BioStocks
$MATN (fka $OXGN) Receives FDA Fast Track Designation for OXi4503 in Patients with AML
June 7th 2017, 7:06am
specstockspulse @specstockspulse
Get your say in on $OXGN at SpeculatingStocks, the discovery engine. https://t.co/O3Ny1no8ww #stocks https://t.co/O3Ny1no8ww
May 21st 2017, 7:05am
box_of_news @box_of_news
$OXGN: New SEC Filing for OXGN: Form S-1 (No. 0001193125-17-167444): https://t.co/AzppOL5DDD
May 11th 2017, 5:05pm
MyAlliesTrading @MyAlliesTrading
$OXGN Mateon Provides Corporate Update and Reports First Quarter 2017 Financial Results https://t.co/p6XsgKZeDg
May 8th 2017, 4:05pm
Allstocknews @Allstocknews
$OXGN Mateon Provides Corporate Update and Reports First Quarter 2017 Financial Results From our Stock News Alerts App
May 8th 2017, 4:05pm
MyAlliesTrading @MyAlliesTrading
$OXGN Mateon Therapeutics Announces Presentations at the Tumor Microenvironment Workshop https://t.co/RU3RaduxMS
April 27th 2017, 5:04pm
Allstocknews @Allstocknews
$OXGN Mateon Therapeutics Announces Presentations at the Tumor Microenvironment Workshop From our Stock News Alerts App
April 27th 2017, 9:04am
jeff90lx @jeff90lx
RT @Allstocknews: $OXGN Mateon Announces Initiation of Investigator-Sponsored Phase 1 Study of CA4P in Combination with Everoli From our St…
April 26th 2017, 4:04pm
QLFilings @QLFilings
$OXGN filed Form DEF 14A with the SEC. Most mentioned words: dr, board, compensation, directors, annual
April 26th 2017, 8:04am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.